Vor Biopharma Inc.
VOR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $326 | $203 | $90 | $76 |
| - Cash | $160 | $191 | $50 | $82 |
| + Debt | $3 | $0 | $31 | $32 |
| Enterprise Value | $168 | $12 | $70 | $26 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$813 | -$242 | -$32 | -$30 |
| % Margin | – | – | – | – |
| Net Income | -$813 | -$1,574 | -$32 | -$31 |
| % Margin | – | – | – | – |
| EPS Diluted | -121.63 | -251.2 | -5.2 | -9 |
| % Growth | 51.6% | -4,730.8% | 42.2% | – |
| Operating Cash Flow | -$54 | -$35 | -$31 | -$24 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$54 | -$35 | -$31 | -$24 |